SCHEMBL6804488

SCHEMBL6804488

COc1ccc(-c2sc(Cl)c(C)c2C(C)=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM6 O15303 2/20 0.48
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
CNR1 P21554 2/20 0.46
CNR2 P34972 2/20 0.46
ATM Q13315 1/20 0.46
MAPT P10636 4/20 0.45
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPC1 O15118 1/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 1/20 0.44
TP53 P04637 2/20 0.43
MDM2 Q00987 2/20 0.43
OPRD1 P41143 1/20 0.43
ALOX5 P09917 1/20 0.42
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6803591 0.84 RAB9A (0.45) GRM6LMNAL3MBTL1MAPTALDH1A1
SCHEMBL6803372 0.81 GRM6 (0.55) GRM6LMNAMAPTALDH1A1SMN1; SMN2
SCHEMBL6803007 0.79 NPC1 (0.44) GRM6L3MBTL1TDP1ALDH1A1SMN1; SMN2
SCHEMBL7847013 0.79 GRM6 (0.51) GRM6LMNAL3MBTL1TDP1CNR1
SCHEMBL6809510 0.79 CSNK1A1 (0.50) GRM6MAPTALDH1A1SMN1; SMN2KDM4E
Hydrochloric Acid SCHEMBL6802046 0.78 GRM6 (0.50) GRM6LMNAL3MBTL1TDP1CNR1
SCHEMBL6804497 0.75 BRD4 (0.51) GRM6CNR1MAPTALDH1A1SMN1; SMN2
SCHEMBL14485422 0.69 PTPN1 (0.53) GRM6LMNAL3MBTL1TDP1CNR1
SCHEMBL7207512 0.69 GRM6 (0.71) GRM6MAPTALDH1A1KDM4EGAA
SCHEMBL17043014 0.68 L3MBTL1 (0.49) LMNAL3MBTL1TDP1ATMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142976-A1 Pyridylfuran and pyridylthiophene compounds PFIZER INC. 2004-07-22 US disclosed
US-6696470-B2 FOR THERAPY OF ARTHRITIS, ASTHMA, BONE RESORPTION DISEASE, CACHEXIA, CARDIOVASCULAR DISEASE, CEREBRAL MALARIA, CROHN'S DISEASE, DIABETES, FEVER OR MYALGIA DUE TO INFECTION, GOUT, GRAFT VERSUS HOST REACTION, INFLAMMATION OF ORGANS, ETC. PFIZER INC. 2004-02-24 US disclosed
US-20020022729-A1 Pyridylfuran and pyridylthiophene compounds KAWAI AKIYOSHI (JP) 2002-02-21 US disclosed
EP-0853083-B1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof PFIZER (US) 2001-09-12 EP disclosed
US-6048880-A THERAPY FOR CYTOKINE SENSITIVE DISEASES PFIZER PHARAMACEUTICALS INC. (JP) 2000-04-11 US disclosed
EP-0853083-A1 Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof PFIZER INC. (US) 1998-07-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142976-A1 Pyridylfuran and pyridylthiophene compounds MC2R, FCGR2A, OGFR GRM6 371/4885LMNA 3419/4885L3MBTL1 3138/4885
US-20020022729-A1 Pyridylfuran and pyridylthiophene compounds MC2R, CRHR1, NR3C2 GRM6 384/4885LMNA 3500/4885L3MBTL1 3511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.